News & Events about Fate Therapeutics Inc.
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (NASDAQ: CRBU) Johnson Fistel, LLP is investigating potential claims on behalf of Caribou Biosciences, Inc. ("Caribou" or the "Company") (NASDAQ: CRBU) against certain of its officers and directors. If you are a current, long-term...
StockNews.com lowered shares of Fate Therapeutics (NASDAQ:FATE Get Rating) from a hold rating to a sell rating in a research note released on Tuesday . FATE has been the subject of several other research reports. Bank of America cut Fate Therapeutics from a buy rating to an underperform rating in a ...
Globe Newswire
2 months ago
NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- Sotera Health Co. (NASDAQ: SHC) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Companys made false and misleading representations concerning ...
Ticker Report
2 months ago
Shares of Fate Therapeutics, Inc. (NASDAQ:FATE Get Rating) have been given a consensus rating of Hold by the twenty-three analysts that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell rating, fourteen have assigned a ...